A cough, while common, can signal various underlying conditions ranging from minor irritations to serious health concerns. Dr. Fady Youssef, a board-certified pulmonologist, explains that ...
Please provide your email address to receive an email when new articles are posted on . Poor lung function trajectories were found among those with chronic productive cough and those with intermittent ...
Persistent cough indicates that your body needs attention, often flagging irritated airways or hidden issues in both kids and adults. Lasting over 3-4 weeks, it's your lungs' way of clearing threats ...
Chronic cough took center stage at the European Respiratory Society (ERS) Congress session titled "Conditions We Are Just Dealing With the Tip of the Iceberg in Primary Care: Frequently Mismanaged ...
Add Yahoo as a preferred source to see more of our stories on Google. Coughs are common during every winter virus season. But this year it seems like more people than usual are complaining about a ...
If you've found yourself dealing with a nasty, lingering cough, you're not alone. With respiratory illnesses surging across the country right now, it's no surprise that so many people are hacking for ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with chronic vs. non-chronic cough faced a higher ...
Based on the researchers’ findings, gefapixant provides small benefits in cough severity, cough frequency, and cough-specific quality of life in patients with refractory or unexplained chronic coughs.
The Weather Channel on MSN
I’m Over This Cold, So Why Am I Still Coughing?
That persistent tickle in your throat doesn’t usually mean you’re still sick. Here’s why cold symptoms can stick around after ...
A drug Merck is developing for chronic cough failed to win over a panel of advisors to the Food and Drug Administration on Friday, making approval unlikely. The FDA’s Pulmonary-allergy Drugs Advisory ...
The Company will conduct two Phase 3 clinical trials of nalbuphine ER for the treatment of patients with IPF-related chronic cough First pivotal trial is on track to initiate in the second quarter of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results